Umbilical cord-derived mesenchymal stem cell secretome promotes skin regeneration and rejuvenation: From mechanism to therapeutics

Abstract

How to effectively repair cutaneous wounds and promote skin rejuvenation has always been a challenging issue for clinical medicine and medical aesthetics. Current conventional medicines exhibit several drawbacks, including limited therapeutic effects, prolonged treatment periods, and high costs. As a novel cell-free therapy, the umbilical cord-derived mesenchymal stem cell (UCMSC) secretome may offer a promising approach for skin regeneration and rejuvenation. The UCMSC secretome is a collection of all proteins secreted by mesenchymal stem cells, including conditioned media, exosomes, and other substances. The UCMSC secretome has numerous abilities to accelerate acute wound healing, including high fibroblast and keratinocyte proliferative activity, pro-angiogenesis, anti-inflammation, anti-fibrosis, and anti-oxidative stress. Its impact on the four stages of wound healing is manifested by inducing the haemostasis phase, inhibiting the inflammation phase, promoting the proliferation phase, and regulating the remodelling phase. Furthermore, it is highly effective in the treatment of chronic wounds, alopecia, aging, and skin homeostasis disturbance. This review focuses on the clinical therapies and application prospects of the UCMSC secretome, encompassing its source, culture, separation, identification, storage, and pretreatment. Additionally, a discussion on the dosage, administration route, efficacy, and biosafety in the clinical situation is presented. This review aims to provide scientific support for the mechanistic investigation and clinical utilisation of the UCMSC secretome in wound healing and skin rejuvenation.

References

[1] Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med. 2014;6:265sr6.

[2] Ding D-C, Chang Y-H, Shyu W-C, Lin S-Z. Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy. Cell Transplant. 2015;24:339-347.

[3] Hoang DH, Nguyen TD, Nguyen HP, et al. Differential wound healing capacity of mesenchymal stem cell-derived exosomes originated from bone marrow, adipose tissue and umbilical cord under serum- and Xeno-free condition. Front Mol Biosci. 2020;7:119.

[4] Montero-Vilchez T, Sierra-Sánchez Á, Sanchez-Diaz M, et al. Mesenchymal stromal cell-conditioned medium for skin diseases: a systematic review. Front Cell Dev Biol. 2021;9:654210.

[5] Abbaszadeh H, Ghorbani F, Derakhshani M, Movassaghpour A, Yousefi M. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles: a novel therapeutic paradigm. J Cell Physiol. 2020;235:706-717.

[6] Yang S, Huang S, Feng C, Fu X. Umbilical cord-derived mesenchymal stem cells: strategies, challenges, and potential for cutaneous regeneration. Front Med. 2012;6:41-47.

[7] Ai A, Amini-Nik S, Blit PH, et al. Human Wharton's jelly mesenchymal stem cells promote skin wound healing through paracrine signaling. Stem Cell Res Ther. 2014;5:28.

[8] Bakhtyar N, Jeschke MG, Herer E, Sheikholeslam M, Amini-Nik S. Exosomes from acellular Wharton's jelly of the human umbilical cord promotes skin wound healing. Stem Cell Res Ther. 2018;9:193.

[9] Md Fadilah NI, Jailani MSMAK, Hisham MAIB, et al. Cell secretomes for wound healing and tissue regeneration: next generation acellular based tissue engineered products. J Tissue Eng. 2022;13:204173142211142.

[10] Hoss E, Kollipara R, Alhaddad M, Boen M, Goldman MP. Red deer umbilical cord-derived stem cell conditioned media combined with ablative resurfacing of the face. J Drugs Dermatol JDD. 2020;19:1044-1048.

[11] Jo H, Brito S, Kwak BM, Park S, Lee MG, Bin BH. Applications of mesenchymal stem cells in skin regeneration and rejuvenation. Int J Mol Sci. 2021;22:2410.

[12] Yin S, Ji C, Wu P, Jin C, Qian H. Human umbilical cord mesenchymal stem cells and exosomes: bioactive ways of tissue injury repair. Am J Transl Res. 2019;11:1230-1240.

[13] Al-Masawa ME, Alshawsh MA, Ng CY, et al. Efficacy and safety of small extracellular vesicle interventions in wound healing and skin regeneration: a systematic review and meta-analysis of animal studies. Theranostics. 2022;12:6455-6508.

[14] Kusindarta DL, Wihadmadyatami H, Fibrianto YH, et al. Human umbilical mesenchymal stem cells conditioned medium promote primary wound healing regeneration. Vet World. 2016;9:605-610.

[15] Zhao W, Zhang R, Zang C, et al. Exosome derived from mesenchymal stem cells alleviates pathological scars by inhibiting the proliferation, migration and protein expression of fibroblasts via delivering miR-138-5p to target SIRT1. Int J Nanomedicine. 2022;17:4023-4038.

[16] Praveen Kumar L, Kandoi S, Misra R, Vijayalakshmi S, Rajagopal K, Verma RS. The mesenchymal stem cell secretome: a new paradigm towards cell-free therapeutic mode in regenerative medicine. Cytokine Growth Factor Rev. 2019;46:1-9.

[17] Yuan A-R, Bian Q, Gao J-Q. Current advances in stem cell-based therapies for hair regeneration. Eur J Pharmacol. 2020;881:173197.

[18] Sipos F, Műzes G. Disagreements in the therapeutic use of mesenchymal stem cell-derived secretome. World J Stem Cells. 2022;14:365-371.

[19] Zeng X, Yi X, Chen L, et al. Characterization and bioassays of extracellular vesicles extracted by tangential flow filtration. Regen Med. 2022;17:141-154.

[20] Zhu Z, Zhang X, Hao H, et al. Exosomes derived from umbilical cord mesenchymal stem cells treat cutaneous nerve damage and promote wound healing. Front Cell Neurosci. 2022;16:913009.

[21] Nakano A, Kageyama T, Ahn B-C. Application of cell-derived extracellular vesicles and engineered nanovesicles for hair growth: from mechanisms to therapeutics. Front Cell Dev Biol. 2022;10:12.

[22] Doyle LM, Wang MZ. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cell. 2019;8:E727.

[23] Maqsood M, Kang M, Wu X, Chen J, Teng L, Qiu L. Adult mesenchymal stem cells and their exosomes: sources, characteristics, and application in regenerative medicine. Life Sci. 2020;256:118002.

[24] Chen G, Chen H, Zeng X, Zhu W. Stem cell-derived exosomal transcriptomes for wound healing. Front Surg. 2022;9:933781.

[25] Bouwstra JA, Honeywell-Nguyen PL. Skin structure and mode of action of vesicles. Adv Drug Deliv Rev. 2002;54(Suppl 1):S41-S55.

[26] Farahani M, Shafiee A. Wound healing: from passive to smart dressings. Adv Healthc Mater. 2021;10:e2100477.

[27] Lazarus GS, Cooper DM, Knighton DR, et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol. 1994;130:489-493.

[28] Sriramulu S, Banerjee A, Jothimani G, Pathak S. Conditioned medium from the human umbilical cord-mesenchymal stem cells stimulate the proliferation of human keratinocytes. J Basic Clin Physiol Pharmacol. 2020;32:51-56.

[29] Kosaric N, Kiwanuka H, Gurtner GC. Stem cell therapies for wound healing. Expert Opin Biol Ther. 2019;19:575-585.

[30] Wilkinson HN, Hardman MJ. Wound healing: cellular mechanisms and pathological outcomes. Open Biol. 2020;10:200223.

[31] Rodrigues M, Kosaric N, Bonham CA, Gurtner GC. Wound healing: a cellular perspective. Physiol Rev. 2019;99:665-706.

[32] Dekoninck S, Blanpain C. Stem cell dynamics, migration and plasticity during wound healing. Nat Cell Biol. 2019;21:18-24.

[33] Fong C-Y, Tam K, Cheyyatraivendran S, et al. Human Wharton's jelly stem cells and its conditioned medium enhance healing of excisional and diabetic wounds. J Cell Biochem. 2014;115:290-302.

[34] Lin C, Gu J, Zhang Y, et al. Effect of UC-MSCs on inflammation and thrombosis of the rats with collagen type II induced arthritis. Zhonghua Xue Ye Xue Za Zhi Zhonghua Xueyexue Zazhi. 2012;33:215-219.

[35] Miranda JP, Filipe E, Fernandes AS, et al. The human umbilical cord tissue-derived MSC population UCX(®) promotes early Motogenic effects on keratinocytes and fibroblasts and G-CSF-mediated mobilization of BM-MSCs when transplanted in vivo. Cell Transplant. 2015;24:865-877.

[36] Li X, Liu L, Yang J, et al. Exosome derived from human umbilical cord mesenchymal stem cell mediates MiR-181c attenuating burn-induced excessive inflammation. EBioMedicine. 2016;8:72-82.

[37] Ti D, Hao H, Fu X, Han W. Mesenchymal stem cells-derived exosomal microRNAs contribute to wound inflammation. Sci China Life Sci. 2016;59:1305-1312.

[38] Alexander M, Hu R, Runtsch MC, et al. Exosome-delivered microRNAs modulate the inflammatory response to endotoxin. Nat Commun. 2015;6:7321.

[39] Nosbaum A, Prevel N, Truong H-A, et al. Cutting edge: regulatory T cells facilitate cutaneous wound healing. J Immunol Baltim MD. 2016;1950(196):2010-2014.

[40] Monguió-Tortajada M, Roura S, Gálvez-Montón C, et al. Nanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: implications for nanomedicine. Theranostics. 2017;7:270-284.

[41] Pachler K, Ketterl N, Desgeorges A, et al. An in vitro potency assay for monitoring the immunomodulatory potential of stromal cell-derived extracellular vesicles. Int J Mol Sci. 2017;18:E1413.

[42] Mokarizadeh A, Delirezh N, Morshedi A, Mosayebi G, Farshid AA, Mardani K. Microvesicles derived from mesenchymal stem cells: potent organelles for induction of tolerogenic signaling. Immunol Lett. 2012;147:47-54.

[43] Wang M, Zhao Y, Zhang Q. Human mesenchymal stem cell-derived exosomes accelerate wound healing of mice eczema. J Dermatol Treat. 2020;1–5:1401-1405.

[44] Zhang Q, Fu L, Liang Y, et al. Exosomes originating from MSCs stimulated with TGF-β and IFN-γ promote Treg differentiation. J Cell Physiol. 2018;233:6832-6840.

[45] Ti D, Hao H, Tong C, et al. LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b. J Transl Med. 2015;13:308.

[46] Song Y, Dou H, Li X, et al. Exosomal miR-146a contributes to the enhanced therapeutic efficacy of interleukin-1β-primed mesenchymal stem cells against sepsis. Stem Cells Dayt Ohio. 2017;35:1208-1221.

[47] Zhang Y, Yan J, Li Z, Zheng J, Sun Q. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate psoriasis-like skin inflammation. J Interferon Cytokine Res. 2022;42:8-18.

[48] Nosrati H, Khodaei M, Alizadeh Z, Banitalebi-Dehkordi M. Cationic, anionic and neutral polysaccharides for skin tissue engineering and wound healing applications. Int J Biol Macromol. 2021;192:298-322.

[49] Zhang B, Wu X, Zhang X, et al. Human umbilical cord mesenchymal stem cell exosomes enhance angiogenesis through the Wnt4/β-catenin pathway. Stem Cells Transl Med. 2015;4:513-522.

[50] Arutyunyan I, Fatkhudinov T, Kananykhina E, et al. Role of VEGF-A in angiogenesis promoted by umbilical cord-derived mesenchymal stromal/stem cells: in vitro study. Stem Cell Res Ther. 2016;7:46.

[51] Kuchroo P, Dave V, Vijayan A, Viswanathan C, Ghosh D. Paracrine factors secreted by umbilical cord-derived mesenchymal stem cells induce angiogenesis in vitro by a VEGF-independent pathway. Stem Cells Dev. 2015;24:437-450.

[52] Amable PR, Teixeira MVT, Carias RBV, Granjeiro JM, Borojevic R. Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly. Stem Cell Res Ther. 2014;5:53.

[53] Edwards SS, Zavala G, Prieto CP, et al. Functional analysis reveals angiogenic potential of human mesenchymal stem cells from Wharton's jelly in dermal regeneration. Angiogenesis. 2014;17:851-866.

[54] Chinnici CM, Iannolo G, Cittadini E, et al. Extracellular vesicle-derived microRNAs of human Wharton's jelly mesenchymal stromal cells may activate endogenous VEGF-A to promote angiogenesis. Int J Mol Sci. 2021;22:2045.

[55] Wang X, Abraham S, McKenzie JAG, et al. LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling. Nature. 2013;499:306-311.

[56] Lai Y, Liu XH, Zeng Y, Zhang Y, Shen Y, Liu Y. Interleukin-8 induces the endothelial cell migration through the Rac 1/RhoA-p38MAPK pathway. Eur Rev Med Pharmacol Sci. 2012;16:630-638.

[57] Shen C, Lie P, Miao T, et al. Conditioned medium from umbilical cord mesenchymal stem cells induces migration and angiogenesis. Mol Med Rep. 2015;12:20-30.

[58] Zhang Y, Zhang P, Gao X, Chang L, Chen Z, Mei X. Preparation of exosomes encapsulated nanohydrogel for accelerating wound healing of diabetic rats by promoting angiogenesis. Mater Sci Eng C Mater Biol Appl. 2021;120:111671.

[59] Liu J, Yan Z, Yang F, et al. Exosomes derived from human umbilical cord mesenchymal stem cells accelerate cutaneous wound healing by enhancing angiogenesis through delivering angiopoietin-2. Stem Cell Rev Rep. 2021;17:305-317.

[60] Shi H, Xu X, Zhang B, et al. 3,3′-diindolylmethane stimulates exosomal Wnt11 autocrine signaling in human umbilical cord mesenchymal stem cells to enhance wound healing. Theranostics. 2017;7:1674-1688.

[61] Zhang B, Shi Y, Gong A, et al. HucMSC exosome-delivered 14-3-3ζ orchestrates self-control of the Wnt response via modulation of YAP during cutaneous regeneration: the HucMSC exosome controls wound healing via YAP. Stem Cells. 2016;34:2485-2500.

[62] Zhang S, Chen L, Zhang G, Zhang B. Umbilical cord-matrix stem cells induce the functional restoration of vascular endothelial cells and enhance skin wound healing in diabetic mice via the polarized macrophages. Stem Cell Res Ther. 2020;11:39.

[63] Nie W, Huang X, Zhao L, et al. Exosomal miR-17-92 derived from human mesenchymal stem cells promotes wound healing by enhancing angiogenesis and inhibiting endothelial cell ferroptosis. Tissue Cell. 2023;83:102124.

[64] Yang K, Li D, Wang M, et al. Exposure to blue light stimulates the proangiogenic capability of exosomes derived from human umbilical cord mesenchymal stem cells. Stem Cell Res Ther. 2019;10:358.

[65] Li M, Luan F, Zhao Y, et al. Mesenchymal stem cell-conditioned medium accelerates wound healing with fewer scars. Int Wound J. 2017;14:64-73.

[66] Santos JM, Camões SP, Filipe E, et al. Three-dimensional spheroid cell culture of umbilical cord tissue-derived mesenchymal stromal cells leads to enhanced paracrine induction of wound healing. Stem Cell Res Ther. 2015;6:90.

[67] Xiaojie W, Banda J, Qi H, et al. Scarless wound healing: current insights from the perspectives of TGF-β, KGF-1, and KGF-2. Cytokine Growth Factor Rev. 2022;66:26-37.

[68] Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. PERSPECTIVE ARTICLE: growth factors and cytokines in wound healing: growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16:585-601.

[69] Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, DiPietro L. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol. 1998;152:1445-1452.

[70] Vu DM, Nguyen VT, Nguyen TH, et al. Effects of extracellular vesicles secreted by TGFβ-stimulated umbilical cord mesenchymal stem cells on skin fibroblasts by promoting fibroblast migration and ECM protein production. Biomedicine. 2022;10:1810.

[71] Li M, Zhao Y, Hao H, et al. Umbilical cord-derived mesenchymal stromal cell-conditioned medium exerts in vitro antiaging effects in human fibroblasts. Cytotherapy. 2017;19:371-383.

[72] Deng M, Yu TZ, Li D, et al. Human umbilical cord mesenchymal stem cell-derived and dermal fibroblast-derived extracellular vesicles protect dermal fibroblasts from ultraviolet radiation-induced photoaging in vitro. Photochem Photobiol Sci. 2020;19:406-414.

[73] Fong C-Y, Biswas A, Subramanian A, Srinivasan A, Choolani M, Bongso A. Human keloid cell characterization and inhibition of growth with human Wharton's jelly stem cell extracts. J Cell Biochem. 2014;115:826-838.

[74] Arjunan S, Gan SU, Choolani M, et al. Inhibition of growth of Asian keloid cells with human umbilical cord Wharton's jelly stem cell-conditioned medium. Stem Cell Res Ther. 2020;11:78.

[75] Zhou P, Li X, Zhang B, Shi Q, Li D, Ju X. A human umbilical cord mesenchymal stem cell-conditioned medium/chitosan/collagen/β-glycerophosphate thermosensitive hydrogel promotes burn injury healing in mice. Biomed Res Int. 2019;2019:5768285.

[76] Tam K, Cheyyatraviendran S, Venugopal J, et al. A nanoscaffold impregnated with human wharton's jelly stem cells or its secretions improves healing of wounds. J Cell Biochem. 2014;115:794-803.

[77] Zhao G, Liu F, Liu Z, et al. MSC-derived exosomes attenuate cell death through suppressing AIF nucleus translocation and enhance cutaneous wound healing. Stem Cell Res Ther. 2020;11:174.

[78] Kondo T, Ishida Y. Molecular pathology of wound healing. Forensic Sci Int. 2010;203:93-98.

[79] Zhang B, Wang M, Gong A, et al. HucMSC-exosome mediated-Wnt4 signaling is required for cutaneous wound healing. Stem Cells Dayt Ohio. 2015;33:2158-2168.

[80] Blockhuys S, Liu N, Agarwal NR, Enejder A, Loitto V, Sun XF. X-radiation enhances the collagen type I strap formation and migration potentials of colon cancer cells. Oncotarget. 2016;7:71390-71399.

[81] Friedl P, Wolf K. Plasticity of cell migration: a multiscale tuning model. J Cell Biol. 2010;188:11-19.

[82] Peng C, He Q, Luo C. Lack of keratinocyte growth factor retards angiogenesis in cutaneous wounds. J Int Med Res. 2011;39:416-423.

[83] Teng L, Maqsood M, Zhu M, et al. Exosomes derived from human umbilical cord mesenchymal stem cells accelerate diabetic wound healing via promoting M2 macrophage polarization, angiogenesis, and collagen deposition. Int J Mol Sci. 2022;23:10421.

[84] Hu J, Chen Y, Huang Y, Su Y. Human umbilical cord mesenchymal stem cell-derived exosomes suppress dermal fibroblasts-myofibroblats transition via inhibiting the TGF-β1/Smad 2/3 signaling pathway. Exp Mol Pathol. 2020;115:104468.

[85] Fang S, Xu C, Zhang Y, et al. Umbilical cord-derived mesenchymal stem cell-derived exosomal MicroRNAs suppress myofibroblast differentiation by inhibiting the transforming growth factor-β/SMAD2 pathway during wound healing. Stem Cells Transl Med. 2016;5:1425-1439.

[86] Li M, Zhang HP, Wang XY, Chen ZG, Lin XF, Zhu W. Mesenchymal stem cell-derived exosomes ameliorate dermal fibrosis in a murine model of bleomycin-induced scleroderma. Stem Cells Dev. 2021;30:981-990.

[87] Bowers S, Franco E. Chronic wounds: evaluation and management. Am Fam Physician. 2020;101:159-166.

[88] Martin P, Nunan R. Cellular and molecular mechanisms of repair in acute and chronic wound healing. Br J Dermatol. 2015;173:370-378.

[89] Morton LM, Phillips TJ. Wound healing and treating wounds. J Am Acad Dermatol. 2016;74:589-605.

[90] Castleberry SA, Almquist BD, Li W, et al. Self-assembled wound dressings silence MMP-9 and improve diabetic wound healing in vivo. Adv Mater Deerfield Beach Fla. 2016;28:1809-1817.

[91] Holl J, Kowalewski C, Zimek Z, et al. Chronic diabetic wounds and their treatment with skin substitutes. Cell. 2021;10:655.

[92] Shrestha C, Zhao L, Chen K, He H, Mo Z. Enhanced healing of diabetic wounds by subcutaneous administration of human umbilical cord derived stem cells and their conditioned media. Int J Endocrinol. 2013;2013:592454.

[93] Yan C, Xv Y, Lin Z, et al. Human umbilical cord mesenchymal stem cell-derived exosomes accelerate diabetic wound healing via ameliorating oxidative stress and promoting angiogenesis. Front Bioeng Biotechnol. 2022;10:829868.

[94] Liang Z-H, Lin SS, Pan NF, et al. UCMSCs-derived exosomal circHIPK3 promotes ulcer wound angiogenesis of diabetes mellitus via miR-20b-5p/Nrf2/VEGFA axis. Diabet Med J Br Diabet Assoc. 2023;40:e14968.

[95] Zhang Y, Wang Y, Shao L, et al. Knockout of beta-2 microglobulin reduces stem cell-induced immune rejection and enhances ischaemic hindlimb repair via exosome/miR-24/Bim pathway. J Cell Mol Med. 2020;24:695-710.

[96] Gu Y, Han J, Jiang C, Zhang Y. Biomarkers, oxidative stress and autophagy in skin aging. Ageing Res Rev. 2020;59:101036.

[97] Zou X, Zou D, Li L, et al. Multi-omics analysis of an in vitro photoaging model and protective effect of umbilical cord mesenchymal stem cell-conditioned medium. Stem Cell Res Ther. 2022;13:435.

[98] Liu Q, Luo Z, He S, et al. Conditioned serum-free medium from umbilical cord mesenchymal stem cells has anti-photoaging properties. Biotechnol Lett. 2013;35:1707-1714.

[99] Wu P, Zhang B, Han X, et al. HucMSC exosome-delivered 14-3-3ζ alleviates ultraviolet radiation-induced photodamage via SIRT1 pathway modulation. Aging. 2021;13:11542-11563.

[100] Mathen C, Dsouza W. In vitro and clinical evaluation of umbilical cord-derived mesenchymal stromal cell-conditioned media for hair regeneration. J Cosmet Dermatol. 2022;21:740-749.

[101] Dong L, Hao H, Liu J, et al. A conditioned medium of umbilical cord mesenchymal stem cells overexpressing Wnt7a promotes wound repair and regeneration of hair follicles in mice. Stem Cells Int. 2017;2017:3738071.

[102] Park YM, Lee M, Jeon S, Hrůzová D. In vitro effects of conditioned medium from bioreactor cultured human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) on skin-derived cell lines. Regen Ther. 2021;18:281-291.

[103] Wang X, Wang Q, Yin P, et al. Secretome of human umbilical cord mesenchymal stem cell maintains skin homeostasis by regulating multiple skin physiological function. Cell Tissue Res. 2022;391:111-125.

[104] Ye C, Zhang Y, Su Z, et al. hMSC exosomes as a novel treatment for female sensitive skin: an in vivo study. Front Bioeng Biotechnol. 2022;10:1053679.

[105] Liang X, Li J, Yan Y, et al. Efficacy of microneedling combined with local application of human umbilical cord-derived mesenchymal stem cells conditioned media in skin brightness and rejuvenation: a randomized controlled split-face study. Front Med. 2022;9:837332.

[106] Kim JY, Rhim WK, Seo HJ, Lee JY, Park CG, Han DK. Comparative analysis of MSC-derived exosomes depending on cell culture Media for Regenerative Bioactivity. Tissue Eng Regen Med. 2021;18:355-367.

[107] Faruqu FN, Liam-Or R, Zhou S, Nip R, Al-Jamal KT. Defined serum-free three-dimensional culture of umbilical cord-derived mesenchymal stem cells yields exosomes that promote fibroblast proliferation and migration in vitro. FASEB J. 2021;35:e21206.

[108] Liu S-J, Meng MY, Han S, et al. Umbilical cord mesenchymal stem cell-derived exosomes ameliorate HaCaT cell photo-aging. Rejuvenation Res. 2021;24:283-293.

[109] Zhang X-F, Wang T, Wang ZX, et al. Hypoxic ucMSC-secreted exosomal miR-125b promotes endothelial cell survival and migration during wound healing by targeting TP53INP1. Mol Ther Nucleic Acids. 2021;26:347-359.

[110] Hendrawan S, Kusnadi Y, Lagonda CA, et al. Wound healing potential of human umbilical cord mesenchymal stem cell conditioned medium: an in vitro and in vivo study in diabetes-induced rats. Vet World. 2021;14:2109-2117.

[111] Kim JY, Rhim W-K, Yoo Y-I, et al. Defined MSC exosome with high yield and purity to improve regenerative activity. J Tissue Eng. 2021;12:20417314211008626.

[112] Wang L, Abhange KK, Wen Y, et al. Preparation of engineered extracellular vesicles derived from human umbilical cord mesenchymal stem cells with ultrasonication for skin rejuvenation. ACS Omega. 2019;4:22638-22645.

[113] Rohde E, Pachler K, Gimona M. Manufacturing and characterization of extracellular vesicles from umbilical cord-derived mesenchymal stromal cells for clinical testing. Cytotherapy. 2019;21:581-592.

[114] Levy D, Jeyaram A, Born LJ, et al. Impact of storage conditions and duration on function of native and cargo-loaded mesenchymal stromal cell extracellular vesicles. Cytotherapy. 2022;25:502-509.

[115] Liu C, Lu Y, du P, et al. Mesenchymal stem cells pretreated with proinflammatory cytokines accelerate skin wound healing by promoting macrophages migration and M2 polarization. Regen Ther. 2022;21:192-200.

[116] Tai L, Saffery NS, Chin SP, Cheong SK. Secretome profile of TNF-α-induced human umbilical cord mesenchymal stem cells unveils biological processes relevant to skin wound healing. Regen Med. 2023;18:839-856.

[117] Sabzevari R, Roushandeh AM, Mehdipour A, Alini M, Roudkenar MH. SA/G hydrogel containing hCAP-18/LL-37-engineered WJ-MSCs-derived conditioned medium promoted wound healing in rat model of excision injury. Life Sci. 2020;261:118381.

[118] Shu F, Lu J, Zhang W, et al. JAM-A overexpression in human umbilical cord-derived mesenchymal stem cells accelerated the angiogenesis of diabetic wound by enhancing both paracrine function and survival of mesenchymal stem cells. Stem Cell Rev Rep. 2023;19:1554-1575.

[119] Li X, Wang Y, Shi L, et al. Magnetic targeting enhances the cutaneous wound healing effects of human mesenchymal stem cell-derived iron oxide exosomes. J Nanobiotechnol. 2020;18:113.

[120] Zhao X, Fu L, Zou H, et al. Optogenetic engineered umbilical cord MSC-derived exosomes for remodeling of the immune microenvironment in diabetic wounds and the promotion of tissue repair. J Nanobiotechnol. 2023;21:176.

[121] Mathen C, Ghag Sawant M, Gupta R, Dsouza W, Krishna SG. Evaluation of potential application of Wharton's jelly-derived human mesenchymal stromal cells and its conditioned media for dermal regeneration using rat wound healing model. Cells Tissues Organs. 2021;210:31-44.

[122] Wang T, Gao H, Wang D, et al. Stem cell-derived exosomes in the treatment of melasma and its percutaneous penetration. Lasers Surg Med. 2022;55:178-189.

[123] Ahn H, Lee SY, Jung WJ, Lee K-H. Alopecia treatment using minimally manipulated human umbilical cord-derived mesenchymal stem cells: three case reports and review of literature. World J Clin Cases. 2021;9:3741-3751.

[124] Abdul Kareem N, Aijaz A, Jeschke MG. Stem cell therapy for burns: story so far. Biol Targets Ther. 2021;15:379-397.

[125] Yang J, Chen Z, Pan D, Li H, Shen J. Umbilical cord-derived mesenchymal stem cell-derived exosomes combined Pluronic F127 hydrogel promote chronic diabetic wound healing and complete skin regeneration. Int J Nanomedicine. 2020;15:5911-5926.

[126] Zhang X, Ding P, Chen Y, Lin Z, Zhao X, Xie H. Human umbilical cord mesenchymal stem cell-derived exosomes combined with gelatin methacryloyl hydrogel to promote fractional laser injury wound healing. Int Wound J. 2023;20:4040-4049.

[127] Han C, Liu F, Zhang Y, et al. Human umbilical cord mesenchymal stem cell derived exosomes delivered using silk fibroin and sericin composite hydrogel promote wound healing. Front Cardiovasc Med. 2021;8:713021.

[128] Chen J, Liu Y, Zhang J, et al. External application of human umbilical cord-derived mesenchymal stem cells in hyaluronic acid gel repairs foot wounds of types I and II diabetic rats through paracrine action mode. Stem Cells Transl Med. 2023;12:689-706.

[129] Ferroni L, Gardin C, D'Amora U, et al. Exosomes of mesenchymal stem cells delivered from methacrylated hyaluronic acid patch improve the regenerative properties of endothelial and dermal cells. Biomater Adv. 2022;139:213000.

[130] Koken GY, Abamor ES, Diyev AA, Karaoz E. Wharton jelly derived mesenchymal stem cell's exosomes demonstrate significant antileishmanial and wound healing effects in combination with aloe-emodin: an in vitro study. J Pharm Sci. 2022;12(22):3232-3242.

[131] Zhang K, Yu L, Li FR, et al. Topical application of exosomes derived from human umbilical cord mesenchymal stem cells in combination with sponge spicules for treatment of photoaging. Int J Nanomedicine. 2020;15:2859-2872.

[132] Tan ST, Aisyah PB, Firmansyah Y, Nathasia N, Budi E, Hendrawan S. Effectiveness of Secretome from human umbilical cord mesenchymal stem cells in gel (10% SM-hUCMSC gel) for chronic wounds (diabetic and trophic ulcer)—phase 2 clinical trial. J Multidiscip Healthc. 2023;16:1763-1777.

RIGHTS & PERMISSIONS

2023 2023 The Authors. Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.